Literature DB >> 6153102

Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and Treponema pallidum antigens.

S A Lukehart, S A Baker-Zander, S Sell.   

Abstract

Lymphoid cells from spleens and lymph nodes of rabbits infected with T. pallidum respond by proliferation to concanavalin A (Con A) and T. pallidum antigens. Spleen cell responsiveness to treponemal antigens appears 6 days after infection, is 100 to 600 fold higher than the response of uninfected control rabbits, and is maintained throughout the 31-day observation period. Specifically responding cells in the inguinal and popliteal lymph nodes of infected animals are demonstrable on day 10, and the magnitude of the response increases throughout the observation period. Specific responsiveness to T. pallidum antigens in vitro is enhanced in purified T cell populations and is abolished by treatment with goat anti-rabbit thymocyte serum and complement. The response of spleen and lymph node cells to Con A is unaffected during syphilitic infection. These results are consistent with a role for T cell-mediated specific immunity to treponemal antigens early after infection and do not support a hypothesis of depressed cellular immunity during syphilitic infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153102

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Comparative investigation of the genomic regions involved in antigenic variation of the TprK antigen among treponemal species, subspecies, and strains.

Authors:  Lorenzo Giacani; Stephanie L Brandt; Maritza Puray-Chavez; Tara Brinck Reid; Charmie Godornes; Barbara J Molini; Martin Benzler; Jörg S Hartig; Sheila A Lukehart; Arturo Centurion-Lara
Journal:  J Bacteriol       Date:  2012-06-01       Impact factor: 3.490

2.  Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum.

Authors:  Brandon T Leader; Karin Hevner; Barbara J Molini; Lynn K Barrett; Wesley C Van Voorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  The tprK gene is heterogeneous among Treponema pallidum strains and has multiple alleles.

Authors:  A Centurion-Lara; C Godornes; C Castro; W C Van Voorhis; S A Lukehart
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Ability of macrophages to process and present Treponema pallidum Bosnia A strain antigens in experimental syphilis of syrian hamsters.

Authors:  O Bagasra; I Damjanov
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

5.  Activation of macrophages by products of lymphocytes from normal and syphilitic rabbits.

Authors:  S A Lukehart
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

6.  Murine monoclonal antibodies specific for virulent Treponema pallidum (Nichols).

Authors:  S M Robertson; J R Kettman; J N Miller; M V Norgard
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Response of syphilitic rabbits to reinfection with homologous and heterologous Treponema pallidum strains.

Authors:  R A Strugnell; S Faine; S Graves
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Antigenic cross-reactivity between Treponema pallidum and other pathogenic members of the family Spirochaetaceae.

Authors:  S A Baker-Zander; S A Lukehart
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

9.  Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase.

Authors:  C E Cameron; C Castro; S A Lukehart; W C Van Voorhis
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Efficacy of aztreonam in treatment of experimental syphilis in rabbits.

Authors:  S A Lukehart; S A Baker-Zander; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.